Schönherr O T, Houwink E H
Antonie Van Leeuwenhoek. 1984;50(5-6):597-623. doi: 10.1007/BF02386229.
Antibody engineering is the selection process enabling the isolation of hybridoma clones, each of which produces an antibody with predefined qualities. The state of the art of hybridoma technology is reviewed with emphasis on the results obtained by antibody engineering in our laboratories for the development of monoclonal antibodies for specific use in diagnostic tests. The perspective for in vitro monoclonal antibody production as well as the application of monoclonal antibodies for diagnostic reagents, industrial purification and therapeutic use are indicated.
抗体工程是一种筛选过程,可分离杂交瘤克隆,每个克隆都能产生具有预定特性的抗体。本文回顾了杂交瘤技术的发展现状,重点介绍了我们实验室通过抗体工程获得的成果,这些成果用于开发在诊断测试中特定用途的单克隆抗体。文中还指出了体外生产单克隆抗体的前景以及单克隆抗体在诊断试剂、工业纯化和治疗用途方面的应用。